Research graph
References from Association of soluble epoxide hydrolase in neonatal cord blood with symptoms of autism spectrum disorder: Hamamatsu Birth Cohort for Mothers and Children (HBC Study). Local targets link to admitted publications; unresolved targets remain external evidence.
Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study
10.1016/j.cyto.2012.11.015 · 2013 · External reference
Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort
10.1016/j.bbi.2011.09.003 · 2012 · External reference
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
10.1016/j.jneuroim.2010.10.025 · 2011 · External reference
Chemokines and their receptors in the central nervous system
10.1006/frne.2001.0214 · 2001 · External reference
The immune system and developmental programming of brain and behavior
10.1016/j.yfrne.2012.08.006 · 2012 · External reference
Eicosanoids
10.1042/ebc20190083 · 2020 · External reference
Placental abundance of arachidonic acid metabolites is reduced in preterm placentas but is not altered in fetal growth restriction
10.1016/j.plefa.2026.102761 · 2026 · External reference
Autism risk factors: genes, environment, and gene-environment interactions
10.31887/dcns.2012.14.3/pchaste · 2012 · External reference
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta
10.1097/hjh.0000000000000942 · 2016 · External reference
Monocyte chemoattractant protein-1 (MCP-1): an overview
10.1089/jir.2008.0027 · 2009 · External reference
Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues
10.1177/002215540405200403 · 2004 · External reference
Maternal immune activation: implications for neuropsychiatric disorders
10.1126/science.aag3194 · 2016 · External reference
Advances in our understanding of oxylipins derived from dietary PUFAs
10.3945/an.114.007732 · 2015 · External reference
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: a case-control study
10.1186/2040-2392-2-13 · 2011 · External reference
Soluble epoxide hydrolase: gene structure, expression and deletion
10.1016/j.gene.2013.05.008 · 2013 · External reference
Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders
10.3389/fphar.2019.00036 · 2019 · External reference
Arachidonic acid-derived dihydroxy fatty acids in neonatal cord blood relate symptoms of autism spectrum disorders and social adaptive functioning: Hamamatsu Birth Cohort for mothers and children (HBC study)
10.1111/pcn.13710 · 2024 · External reference
Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
10.1186/s12974-019-1508-2 · 2019 · External reference
Replication of standardized ADOS domain scores in the simons simplex collection
10.1002/aur.1474 · 2015 · External reference
Epoxylipids and soluble epoxide hydrolase in heart diseases
10.1016/j.bcp.2021.114866 · 2022 · External reference
Sex differences in immune responses
10.1038/nri.2016.90 · 2016 · External reference
Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia
10.2741/2889 · 2008 · External reference
Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo
10.1194/jlr.m031914 · 2013 · External reference
Autism
10.1016/s0140-6736(13)61539-1 · 2014 · External reference
Nanobody based immunoassay for human soluble epoxide hydrolase detection using polymeric horseradish peroxidase (PolyHRP) for signal enhancement: the rediscovery of PolyHRP?
10.1021/acs.analchem.7b01247 · 2017 · External reference
Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications
10.1159/000345599 · 2013 · External reference
The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism
10.1023/a:1005592401947 · 2000 · External reference
Unresolved reference
2012 · External reference
Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney
10.1016/j.jbc.2021.100667 · 2021 · External reference
Maternal lifestyle and environmental risk factors for autism spectrum disorders
10.1093/ije/dyt282 · 2014 · External reference
Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation
10.1073/pnas.1819234116 · 2019 · External reference
Activity of sEH and oxidant status during systemic bovine coliform mastitis
2021 · External reference
Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses
10.1186/s13229-017-0121-4 · 2017 · External reference
Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health
10.1146/annurev-pharmtox-011112-140244 · 2013 · External reference
Soluble epoxide hydrolase dimerization is required for hydrolase activity
10.1074/jbc.m112.429258 · 2013 · External reference
Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression
10.2133/dmpk.24.438 · 2009 · External reference
Synaptic pruning by microglia is necessary for normal brain development
10.1126/science.1202529 · 2011 · External reference
Polymorphisms in human soluble epoxide hydrolase
10.1124/mol.64.2.482 · 2003 · External reference
Maternal glyphosate exposure causes autism-like behaviors in offspring through increased expression of soluble epoxide hydrolase
10.1073/pnas.1922287117 · 2020 · External reference
Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes
10.1002/jnr.21827 · 2009 · External reference
The role of soluble epoxide hydrolase in preeclampsia
10.1016/j.mehy.2017.07.033 · 2017 · External reference
Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years - autism and developmental disabilities monitoring network, 16 sites, United States, 2022
10.15585/mmwr.ss7402a1 · 2025 · External reference
Altered plasma levels of chemokines in autism and their association with social behaviors
10.1016/j.psychres.2016.07.057 · 2016 · External reference
Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor
10.1073/pnas.0409591102 · 2005 · External reference
Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure
10.1016/j.abb.2004.05.003 · 2004 · External reference
Assessment of soluble epoxide hydrolase activity in vivo: a metabolomic approach
2020 · External reference
Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders
10.1371/journal.pone.0020470 · 2011 · External reference
Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target
10.1016/j.neubiorev.2018.01.010 · 2018 · External reference
Cohort profile: Hamamatsu birth cohort for mothers and children (HBC study)
10.1093/ije/dyv290 · 2016 · External reference
Sex differences in immune responses
10.1126/science.abe7199 · 2021 · External reference
Searching for very early precursors of autism spectrum disorders: the Hamamatsu Birth Cohort for mothers and children (HBC)
10.1017/s2040174410000140 · 2010 · External reference
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
10.1016/j.pharmthera.2017.06.006 · 2017 · External reference
Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease
10.1165/rcmb.2011-0359oc · 2012 · External reference
Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia
10.1038/jcbfm.2009.65 · 2009 · External reference
Soluble epoxide hydrolase: mechanisms and therapeutic potential in psychiatric and neurological disorders
10.1016/bs.apha.2024.10.007 · 2025 · External reference
